Bone Marrow Grafting for Leukemia and Lymphoma

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 6 versions Re-verified since Aug 26, 2020, no change to tracked fieldsv23-v28
  2. Primary completion date: Dec 2018 to Dec 2069
    • Trial status: Recruiting to Enrolling by Invitation
    • Study completion date: Dec 2019 to Dec 2069
    • Site details revised
    v22
  3. Study description expanded, about 12 wordsv21
  4. 2 versions Re-verified since Apr 21, 2016, no change to tracked fieldsv19-v20
  5. Site contact updatedv18
Show 16 earlier versionsHide 16 earlier versions
  1. Study Status, Study Description, Outcome Measuresv17
  2. Re-verified, no change to tracked fieldsv16
  3. Site contact updatedv15
  4. Site contact updatedv14
  5. 2 versions Re-verified since Oct 31, 2012, no change to tracked fieldsv12-v13
  6. Primary completion date: Dec 2018v11 Show 4 more changesShow less
    • Study completion date: Dec 2019
    • Eligibility criteria revised
    • Site contact updated
    • Study arms: 0 to 1
  7. Eligibility criteria revised
    • Site contact updated
    v10
  8. Re-verified, no change to tracked fieldsv9
  9. Enrollment target: 9999v8 Show 4 more changesShow less
    • Eligibility criteria revised
    • Study description expanded, about 18 words
    • Study site revised
    • Collaborators: 1 to 2
  10. Collaborator revisedv7
  11. 3 versions Re-verified since Jul 5, 2006, no change to tracked fieldsv4-v6
  12. Study Status, Study Description, Conditions, Eligibility, Contacts/Locationsv3
  13. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stanford University
635 trials monitored
See 42 trials at risk
Leukemia
2,969 trials monitored
See 180 trials at risk
The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
Trial Details
NCT Number NCT00186147
Lead Sponsor Stanford University
Collaborators: National Cancer Institute (NCI), National Institutes of Health (NIH)
Conditions
(from sponsor)		 Leukemia, Lymphoma, Hematologic Diseases
Related terms Hematologic Diseases, Leukemia, Lymphoma
Enrollment 9,999 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov